|
1
|
Favoriti P, Carbone G, Greco M, Pirozzi F,
Pirozzi RE and Corcione F: Worldwide burden of colorectal cancer: A
review. Updates Surg. 68:7–11. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bouvard V, Loomis D, Guyton KZ, Grosse Y,
Ghissassi FE, Benbrahim-Tallaa L, Guha N, Mattock H and Straif K;
International Agency for Research on Cancer Monograph Working
Group, : Carcinogenicity of consumption of red and processed meat.
Lancet Oncol. 16:1599–1600. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Johnson CH, Dejea CM, Edler D, Hoang LT,
Santidrian AF, Felding BH, Ivanisevic J, Cho K, Wick EC,
Hechenbleikner EM, et al: Metabolism links bacterial biofilms and
colon carcinogenesis. Cell Metab. 21:891–897. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dejea CM, Wick EC, Hechenbleikner EM,
White JR, Mark Welch JL, Rossetti BJ, Peterson SN, Snesrud EC,
Borisy GG, Lazarev M, et al: Microbiota organization is a distinct
feature of proximal colorectal cancers. Proc Natl Acad Sci USA.
111:18321–18326. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Benson AB, Venook AP, Al-Hawary MM,
Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D,
Engstrom PF, et al: NCCN guidelines insights: Colon cancer, version
2.2018. J Natl Compr Canc Netw. 16:359–369. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guo J, Xu B, Han Q, Zhou H, Xia Y, Gong C,
Dai X, Li Z and Wu G: Ferroptosis: A novel Anti-tumor action for
cisplatin. Cancer Res Treat. 50:445–460. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stockwell BR, Friedmann Angeli JP, Bayir
H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gascón S, Hatzios SK,
Kagan VE, et al: Ferroptosis: A regulated cell death nexus linking
metabolism, redox biology, and disease. Cell. 171:273–285. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An iron-dependent form of nonapoptotic cell
death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu S, He Y, Lin L, Chen P, Chen M and
Zhang S: The emerging role of ferroptosis in intestinal disease.
Cell Death Dis. 12:2892021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yagoda N, von Rechenberg M, Zaganjor E,
Bauer AJ, Yang WS, Fridman DJ, Wolpaw AJ, Smukste I, Peltier JM,
Boniface JJ, et al: RAS-RAF-MEK-dependent oxidative cell death
involving voltage-dependent anion channels. Nature. 447:865–869.
2007. View Article : Google Scholar
|
|
12
|
Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao
N, Sun B and Wang G: Ferroptosis: Past, present and future. Cell
Death Dis. 11:882020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ketelut-Carneiro N and Fitzgerald KA:
Apoptosis, pyroptosis, and Necroptosis-oh my! The many ways a cell
can die. J Mol Biol. 434:1673782022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Aglietti RA and Dueber EC: Recent insights
into the molecular mechanisms underlying pyroptosis and gasdermin
family functions. Trends Immunol. 38:261–271. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fang Y, Tian S, Pan Y, Li W, Wang Q, Tang
Y, Yu T, Wu X, Shi Y, Ma P and Shu Y: Pyroptosis: A new frontier in
cancer. Biomed Pharmacother. 121:1095952020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu X, Zhang Z, Ruan J, Pan Y, Magupalli
VG, Wu H and Lieberman J: Inflammasome-activated gasdermin D causes
pyroptosis by forming membrane pores. Nature. 535:153–158. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun L, Wang H, Wang Z, He S, Chen S, Liao
D, Wang L, Yan J, Liu W, Lei X and Wang X: Mixed lineage kinase
domain-like protein mediates necrosis signaling downstream of RIP3
kinase. Cell. 148:213–227. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Negroni A, Colantoni E, Cucchiara S and
Stronati L: Necroptosis in intestinal inflammation and cancer: New
concepts and therapeutic perspectives. Biomolecules. 10:14312020.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu S, Yao S, Yang H, Liu S and Wang Y:
Autophagy: Regulator of cell death. Cell Death Dis. 14:6482023.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guiney SJ, Adlard PA, Bush AI, Finkelstein
DI and Ayton S: Ferroptosis and cell death mechanisms in
Parkinson's disease. Neurochem Int. 104:34–48. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Do Van B, Gouel F, Jonneaux A, Timmerman
K, Gelé P, Pétrault M, Bastide M, Laloux C, Moreau C, Bordet R, et
al: Ferroptosis, a newly characterized form of cell death in
Parkinson's disease that is regulated by PKC. Neurobiol Dis.
94:169–178. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yan N and Zhang J: Iron metabolism,
ferroptosis, and the links with Alzheimer's disease. Front
Neurosci. 13:14432020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cong L, Dong X, Wang Y, Deng Y, Li B and
Dai R: On the role of synthesized hydroxylated chalcones as dual
functional amyloid-β aggregation and ferroptosis inhibitors for
potential treatment of Alzheimer's disease. Eur J Med Chem.
166:11–21. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Deng G, Li Y, Ma S, Gao Z, Zeng T, Chen L,
Ye H, Yang M, Shi H, Yao X, et al: Caveolin-1 dictates ferroptosis
in the execution of acute immune-mediated hepatic damage by
attenuating nitrogen stress. Free Radic Biol Med. 148:151–161.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Park SJ, Cho SS, Kim KM, Yang JH, Kim JH,
Jeong EH, Yang JW, Han CY, Ku SK, Cho IJ and Ki SH: Protective
effect of sestrin2 against iron overload and ferroptosis-induced
liver injury. Toxicol Appl Pharmacol. 379:1146652019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Z, Wu Y, Yuan S, Zhang P, Zhang J,
Li H, Li X, Shen H, Wang Z and Chen G: Glutathione peroxidase 4
participates in secondary brain injury through mediating
ferroptosis in a rat model of intracerebral hemorrhage. Brain Res.
1701:112–125. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kenny EM, Fidan E, Yang Q, Anthonymuthu
TS, New LA, Meyer EA, Wang H, Kochanek PM, Dixon CE, Kagan VE and
Bayir H: Ferroptosis contributes to neuronal death and functional
outcome after traumatic brain injury. Crit Care Med. 47:410–418.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yao X, Zhang Y, Hao J, Duan HQ, Zhao CX,
Sun C, Li B, Fan BY, Wang X, Li WX, et al: Deferoxamine promotes
recovery of traumatic spinal cord injury by inhibiting ferroptosis.
Neural Regen Res. 14:5322019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang Y, Sun C, Zhao C, Hao J, Zhang Y,
Fan B, Li B, Duan H, Liu C, Kong X, et al: Ferroptosis inhibitor
SRS 16–86 attenuates ferroptosis and promotes functional recovery
in contusion spinal cord injury. Brain Res. 1706:48–57. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shi Z, Yuan S, Shi L, Li J, Ning G, Kong X
and Feng S: Programmed cell death in spinal cord injury
pathogenesis and therapy. Cell Prolif. 54:e129922021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Martin-Sanchez D, Ruiz-Andres O, Poveda J,
Carrasco S, Cannata-Ortiz P, Sanchez-Niño MD, Ruiz Ortega M, Egido
J, Linkermann A, Ortiz A and Sanz AB: Ferroptosis, but not
necroptosis, is important in nephrotoxic folic Acid-induced AKI. J
Am Soc Nephrol. 28:218–229. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Müller T, Dewitz C, Schmitz J, Schröder
AS, Bräsen JH, Stockwell BR, Murphy JM, Kunzendorf U and Krautwald
S: Necroptosis and ferroptosis are alternative cell death pathways
that operate in acute kidney failure. Cell Mol Life Sci.
74:3631–3645. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu B, Zhao C, Li H, Chen X, Ding Y and Xu
S: Puerarin protects against heart failure induced by pressure
overload through mitigation of ferroptosis. Biochem Biophys Res
Commun. 497:233–240. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen X, Xu S, Zhao C and Liu B: Role of
TLR4/NADPH oxidase 4 pathway in promoting cell death through
autophagy and ferroptosis during heart failure. Biochem Biophys Res
Commun. 516:37–43. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li D, Pi W, Sun Z, Liu X and Jiang J:
Ferroptosis and its role in cardiomyopathy. Biomed Pharmacother.
153:1132792022. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ng SW, Norwitz SG and Norwitz ER: The
impact of iron overload and ferroptosis on reproductive disorders
in humans: Implications for preeclampsia. Int J Mol Sci.
20:32832019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ng SW, Norwitz SG, Taylor HS and Norwitz
ER: Endometriosis: The role of iron overload and ferroptosis.
Reprod Sci. 27:1383–1390. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yan HF, Zou T, Tuo QZ, Xu S, Li H, Belaidi
AA and Lei P: Ferroptosis: Mechanisms and links with diseases.
Signal Transduct TargetTher. 6:492021. View Article : Google Scholar
|
|
39
|
Yan H, Talty R, Aladelokun O, Bosenberg M
and Johnson CH: Ferroptosis in colorectal cancer: A future target?
Br J Cancer. 128:1439–1451. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wu T, Wan J, Qu X, Xia K, Wang F, Zhang Z,
Yang M, Wu X, Gao R, Yuan X, et al: Nodal promotes colorectal
cancer survival and metastasis through regulating SCD1-mediated
ferroptosis resistance. Cell Death Dis. 14:2292023. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang Y, Zhang Z, Sun W, Zhang J, Xu Q,
Zhou X and Mao L: Ferroptosis in colorectal cancer: Potential
mechanisms and effective therapeutic targets. Biomed Pharmacother.
153:1135242022. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jiang L, Hickman JH, Wang SJ and Gu W:
Dynamic roles of p53-mediated metabolic activities in ROS-induced
stress responses. Cell Cycle. 14:2881–2885. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Jiang L, Kon N, Li T, Wang SJ, Su T,
Hibshoosh H, Baer R and Gu W: Ferroptosis as a p53-mediated
activity during tumour suppression. Nature. 520:57–62. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li Q, Chen K, Zhang T, Jiang D, Chen L,
Jiang J, Zhang C and Li S: Understanding Sorafenib-induced
ferroptosis and resistance mechanisms: Implications for cancer
therapy. Eur J Pharmacol. 955:1759132023. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chen X, Kang R, Kroemer G and Tang D:
Broadening horizons: The role of ferroptosis in cancer. Nat Rev
Clin Oncol. 18:280–296. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang L, Liu Y, Du T, Yang H, Lei L, Guo M,
Ding HF, Zhang J, Wang H, Chen X and Yan C: ATF3 promotes
Erastin-induced ferroptosis by suppressing system Xc. Cell Death
Differ. 27:662–675. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yang WS and Stockwell BR: Synthetic lethal
screening identifies compounds activating Iron-dependent,
nonapoptotic cell death in oncogenic-RAS-harboring cancer cells.
Chem Biol. 15:234–245. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Sui X, Zhang R, Liu S, Duan T, Zhai L,
Zhang M, Han X, Xiang Y, Huang X, Lin H and Xie T: RSL3 drives
ferroptosis through GPX4 inactivation and ROS production in
colorectal cancer. Front Pharmacol. 9:13712018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Costa I, Barbosa DJ, Benfeito S, Silva V,
Chavarria D, Borges F, Remião F and Silva R: Molecular mechanisms
of ferroptosis and their involvement in brain diseases. Pharmacol
Ther. 244:1083732023. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Harayama T and Riezman H: Understanding
the diversity of membrane lipid composition. Nat Rev Mol Cell Biol.
19:281–296. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kagan VE, Mao G, Qu F, Angeli JP, Doll S,
Croix CS, Dar HH, Liu B, Tyurin VA, Ritov VB, et al: Oxidized
arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem
Biol. 13:81–90. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Koppula P, Zhuang L and Gan B: Cytochrome
P450 reductase (POR) as a ferroptosis fuel. Protein Cell.
12:675–679. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yan B, Ai Y, Sun Q, Ma Y, Cao Y, Wang J,
Zhang Z and Wang X: Membrane damage during ferroptosis is caused by
oxidation of phospholipids catalyzed by the oxidoreductases POR and
CYB5R1. Mol Cell. 81:355–369.e10. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zou Y, Li H, Graham ET, Deik AA, Eaton JK,
Wang W, Sandoval-Gomez G, Clish CB, Doench JG and Schreiber SL:
Cytochrome P450 oxidoreductase contributes to phospholipid
peroxidation in ferroptosis. Nat Chem Biol. 16:302–309. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ning X, Qi H, Yuan Y, Li R, Wang Y, Lin Z
and Yin Y: Identification of a new small molecule that initiates
ferroptosis in cancer cells by inhibiting the system Xc−
to deplete GSH. Eur J Pharmacol. 934:1753042022. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Fan X, Li A, Yan Z, Geng X, Lian L, Lv H,
Gao D and Zhang J: From iron metabolism to ferroptosis: Pathologic
changes in coronary heart disease. Oxid Med Cell Longev.
2022:62918892022. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zhou L, Zhao B, Zhang L, Wang S, Dong D,
Lv H and Shang P: Alterations in cellular iron metabolism provide
more therapeutic opportunities for cancer. Int J Mol Sci.
19:15452018. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Basak T and Kanwar RK: Iron imbalance in
cancer: Intersection of deficiency and overload. Cancer Med.
11:3837–3853. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Chifman J, Laubenbacher R and Torti SV: A
systems biology approach to iron metabolism. Adv Exp Med Biol.
844:201–225. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Han C, Liu Y, Dai R, Ismail N, Su W and Li
B: Ferroptosis and its potential role in human diseases. Front
Pharmacol. 11:2392020. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Manz DH, Blanchette NL, Paul BT, Torti FM
and Torti SV: Iron and cancer: Recent insights. Ann N Y Acad Sci.
1368:149–161. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Zhou B, Liu J, Kang R, Klionsky DJ,
Kroemer G and Tang D: Ferroptosis is a type of Autophagy-dependent
cell death. Semin Cancer Biol. 66:89–100. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Mancias JD, Wang X, Gygi SP, Harper JW and
Kimmelman AC: Quantitative proteomics identifies NCOA4 as the cargo
receptor mediating ferritinophagy. Nature. 509:105–109. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Hou W, Xie Y, Song X, Sun X, Lotze MT, Zeh
HJ III, Kang R and Tang D: Autophagy promotes ferroptosis by
degradation of ferritin. Autophagy. 12:1425–1428. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Xie Y, Hou W, Song X, Yu Y, Huang J, Sun
X, Kang R and Tang D: Ferroptosis: Process and function. Cell Death
Differ. 23:369–379. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Yang J, Mo J, Dai J, Ye C, Cen W, Zheng X,
Jiang L and Ye L: Cetuximab promotes RSL3-induced ferroptosis by
suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant
colorectal cancer. Cell Death Dis. 12:10792021. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Tian X, LI S and Ge G: Apatinib promotes
ferroptosis in colorectal cancer cells by targeting ELOVL6/ACSL4
Signaling. Cancer Manag Res. 13:1333–1342. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Zhu JF, Liu Y, Li WT, Li MH, Zhen CH, Sun
PW, Chen JX, Wu WH and Zeng W: Ibrutinib facilitates the
sensitivity of colorectal cancer cells to ferroptosis through
BTK/NRF2 pathway. Cell Death Dis. 14:1512023. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Zhao X and Chen F: Propofol induces the
ferroptosis of colorectal cancer cells by downregulating STAT3
expression. Oncol Lett. 22:7672021. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Chen H, Qi Q, Wu N, Wang Y, Feng Q, Jin R
and Jiang L: Aspirin promotes RSL3-induced ferroptosis by
suppressing mTOR/SREBP-1/SCD1-mediated lipogenesis in PIK3CA-mutant
colorectal cancer. Redox Biol. 55:1024262022. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Shen Z, Zhao L, Yoo SA, Lin Z, Zhang Y,
Yang W and Piao J: Emodin induces ferroptosis in colorectal cancer
through NCOA4-mediated ferritinophagy and NF-κb pathway
inactivation. Apoptosis. May 5–2024.doi: 10.1007/s10495-024-01973-2
(Epub ahead of print). View Article : Google Scholar
|
|
72
|
Wu Y, Pi D, Zhou S, Yi Z, Dong Y, Wang W,
Ye H, Chen Y, Zuo Q and Ouyang M: Ginsenoside Rh3 induces
pyroptosis and ferroptosis through the Stat3/p53/NRF2 axis in
colorectal cancer cells. Acta Biochim Biophys Sin (Shanghai).
55:587–600. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Ming T, Lei J, Peng Y, Wang M, Liang Y,
Tang S, Tao Q, Wang M, Tang X, He Z, et al: Curcumin suppresses
colorectal cancer by induction of ferroptosis via regulation of p53
and solute carrier family 7 member 11/glutathione/glutathione
peroxidase 4 signaling axis. Phytother Res. 38:3954–3972. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Miyazaki K, Xu C, Shimada M and Goel A:
Curcumin and andrographis exhibit Anti-tumor effects in colorectal
cancer via activation of ferroptosis and dual suppression of
glutathione Peroxidase-4 and ferroptosis suppressor Protein-1.
Pharmaceuticals (Basel). 16:3832023. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Ji X, Chen Z, Lin W, Wu Q, Wu Y, Hong Y,
Tong H, Wang C and Zhang Y: Esculin induces endoplasmic reticulum
stress and drives apoptosis and ferroptosis in colorectal cancer
via PERK regulating eIF2α/CHOP and Nrf2/HO-1 cascades. J
Ethnopharmacol. 328:1181392024. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Lai JQ, Zhao LL, Hong C, Zou QM, Su JX, Li
SJ, Zhou XF, Li ZS, Deng B, Cao J and Qi Q: Baicalein triggers
ferroptosis in colorectal cancer cells via blocking the
JAK2/STAT3/GPX4 axis. Acta Pharmacol Sin. 45:1715–1726. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Li J, Jiang JL, Chen YM and Lu WQ: KLF2
inhibits colorectal cancer progression and metastasis by inducing
ferroptosis via the PI3K/AKT signaling pathway. J Pathol Clin Res.
9:423–435. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Park S, Oh J, Kim M and Jin EJ: Bromelain
effectively suppresses Kras-mutant colorectal cancer by stimulating
ferroptosis. Anim Cells Syst (Seoul). 22:334–340. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Wei R, Zhao Y, Wang J, Yang X, Li S, Wang
Y, Yang X, Fei J, Hao X, Zhao Y, et al: Tagitinin C induces
ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal
cancer cells. Int J Biol Sci. 17:2703–2717. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Ko YH, Domingo-Vidal M, Roche M, Lin Z,
Whitaker-Menezes D, Seifert E, Capparelli C, Tuluc M, Birbe RC,
Tassone P, et al: TP53-inducible glycolysis and apoptosis regulator
(TIGAR) metabolically reprograms carcinoma and stromal cells in
breast cancer. J Biol Chem. 291:26291–26303. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Liu MY, Li HM, Wang XY, Xia R, Li X, Ma
YJ, Wang M and Zhang HS: TIGAR drives colorectal cancer ferroptosis
resistance through ROS/AMPK/SCD1 pathway. Free Radic Biol Med.
182:219–231. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Chaudhary N, Choudhary BS, Shah SG,
Khapare N, Dwivedi N, Gaikwad A, Joshi N, Raichanna J, Basu S,
Gurjar M, et al: Lipocalin 2 expression promotes tumor progression
and therapy resistance by inhibiting ferroptosis in colorectal
cancer. Int J Cancer. 149:1495–1511. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Liu X, Yan C, Chang C, Meng F, Shen W,
Wang S and Zhang Y: FOXA2 suppression by TRIM36 exerts Anti-tumor
role in colorectal cancer via inducing NRF2/GPX4-Regulated
ferroptosis. Adv Sci (Weinh). 10:e23045212023. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Wu W, Zhao Y, Qin B, Jiang X, Wang C, Hu
R, Ma R, Lee MH, Liu H, Li K and Yuan P: Non-canonical role of
UCKL1 on ferroptosis defence in colorectal cancer. EBioMedicine.
93:1046502023. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Martino E, Balestrieri A, Aragona F,
Bifulco G, Mele L, Campanile G, Balestrieri ML and D'Onofrio N:
MiR-148a-3p promotes colorectal cancer cell ferroptosis by
targeting SLC7A11. Cancers (Basel). 15:43422023. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Elrebehy MA, Abdelghany TM, Elshafey MM,
Gomaa MH and Doghish AS: miR-509-5p promotes colorectal cancer cell
ferroptosis by targeting SLC7A11. Pathol Res Pract. 247:1545572023.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Liu L, Yao H, Zhou X, Chen J, Chen G, Shi
X, Wu G, Zhou G and He S: MiR-15a-3p regulates ferroptosis via
targeting glutathione peroxidase GPX4 in colorectal cancer. Mol
Carcinog. 61:301–310. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Fan H, Ai R, Mu S, Niu X, Guo Z and Liu L:
MiR-19a suppresses ferroptosis of colorectal cancer cells by
targeting IREB2. Bioengineered. 13:12021–12029. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Zheng S, Hu L, Song Q, Shan Y, Yin G, Zhu
H, Kong W and Zhou C: miR-545 promotes colorectal cancer by
inhibiting transferring in the non-normal ferroptosis signaling.
Aging. 13:26137–26147. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Han Y, Gao X, Wu N, Jin Y, Zhou H, Wang W,
Liu H, Chu Y, Cao J, Jiang M, et al: Long noncoding RNA LINC00239
inhibits ferroptosis in colorectal cancer by binding to Keap1 to
stabilize Nrf2. Cell Death Dis. 13:7422022. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Binnewies M, Roberts EW, Kersten K, Chan
V, Fearon DF, Merad M, Coussens LM, Gabrilovich DI,
Ostrand-Rosenberg S, Hedrick CC, et al: Understanding the tumor
immune microenvironment (TIME) for effective therapy. Nat Med.
24:541–550. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Chen F, Zhuang X, Lin L, Yu P, Wang Y, Shi
Y, Hu G and Sun Y: New horizons in tumor microenvironment biology:
Challenges and opportunities. BMC Med. 13:452015. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Dai E, Han L, Liu J, Xie Y, Kroemer G,
Klionsky DJ, Zeh HJ, Kang R, Wang J and Tang D: Autophagy-dependent
ferroptosis drives tumor-associated macrophage polarization via
release and uptake of oncogenic KRAS protein. Autophagy.
16:2069–2083. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Ma X, Xiao L, Liu L, Ye L, Su P, Bi E,
Wang Q, Yang M, Qian J and Yi Q: CD36-mediated ferroptosis dampens
intratumoral CD8+ T cell effector function and impairs their
antitumor ability. Cell Metab. 33:1001–1012.e5. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Yao L, Hou J, Wu X, Lu Y, Jin Z, Yu Z, Yu
B, Li J, Yang Z, Li C, et al: Cancer-associated fibroblasts impair
the cytotoxic function of NK cells in gastric cancer by inducing
ferroptosis via iron regulation. Redox Biol. 67:1029232023.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
St Paul M and Ohashi PS: The roles of CD8+
T cell subsets in antitumor immunity. Trends Cell Biol. 30:695–704.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Tang R, Xu J, Zhang B, Liu J, Liang C, Hua
J, Meng Q, Yu X and Shi S: Ferroptosis, necroptosis, and pyroptosis
in anticancer immunity. J Hematol Oncol. 13:1102020. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Han J, Khatwani N, Searles TG, Turk MJ and
Angeles CV: Memory CD8+ T cell responses to cancer. Semin Immunol.
49:1014352020. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Lin Z, Zou S and Wen K: The crosstalk of
CD8+ T cells and ferroptosis in cancer. Front Immunol.
14:12554432024. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Yang C, Zhang Y, Lin S, Liu Y and Li W:
Suppressing the KIF20A/NUAK1/Nrf2/GPX4 signaling pathway induces
ferroptosis and enhances the sensitivity of colorectal cancer to
oxaliplatin. Aging (Albany NY). 13:13515–13534. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Lin JF, Hu PS, Wang YY, Tan YT, Yu K, Liao
K, Wu QN, Li T, Meng Q, Lin JZ, et al: Phosphorylated NFS1 weakens
oxaliplatin-based chemosensitivity of colorectal cancer by
preventing PANoptosis. Signal Transduct Target Ther. 7:542022.
View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Xu Y, Hao J, Chen Q, Qin Y, Qin H, Ren S,
Sun C, Zhu Y, Shao B, Zhang J and Wang H: Inhibition of the
RBMS1/PRNP axis improves ferroptosis resistance-mediated
oxaliplatin chemoresistance in colorectal cancer. Mol Carcinog.
63:224–237. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Li B, Wei Z, Wang Z, Xu F, Yang J, Lin B,
Chen Y, Wenren H, Wu L, Guo X, et al: Fusobacterium nucleatum
induces oxaliplatin resistance by inhibiting ferroptosis through
E-cadherin/β-catenin/GPX4 axis in colorectal cancer. Free Radic
Biol Med. 220:125–138. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Zeng K, Li W, Wang Y, Zhang Z, Zhang L,
Zhang W, Xing Y and Zhou C: Inhibition of CDK1 Overcomes
oxaliplatin resistance by regulating ACSL4-mediated ferroptosis in
colorectal cancer. Adv Sci (Weinh). 10:23010882023. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Liu W, Liu C, Xiao J, Qian C, Chen Z, Lin
W, Zhang Y, Wu J, Zhou R and Zhao L: HTRA1 interacts with SLC7A11
to modulate colorectal cancer chemosensitivity by inhibiting
ferroptosis. Cell Death Discovery. 10:2282024. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Mu M, Zhang Q, Zhao C, Li X, Chen Z, Sun X
and Yu J: 3-Bromopyruvate overcomes cetuximab resistance in human
colorectal cancer cells by inducing Autophagy-dependent
ferroptosis. Cancer Gene Therapy. 30:1414–1425. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Chen P, Li X, Zhang R, Liu S, Xiang Y,
Zhang M, Chen X, Pan T, Yan L, Feng J, et al: Combinative treatment
of β-elemene and cetuximab is sensitive to KRAS mutant colorectal
cancer cells by inducing ferroptosis and inhibiting
Epithelial-mesenchymal transformation. Theranostics. 10:5107–5119.
2020. View Article : Google Scholar : PubMed/NCBI
|
